Your browser doesn't support javascript.
loading
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease.
Schäffner, Erik; Bosch-Queralt, Mar; Edgar, Julia M; Lehning, Maria; Strauß, Judith; Fleischer, Niko; Kungl, Theresa; Wieghofer, Peter; Berghoff, Stefan A; Reinert, Tilo; Krueger, Martin; Morawski, Markus; Möbius, Wiebke; Barrantes-Freer, Alonso; Stieler, Jens; Sun, Ting; Saher, Gesine; Schwab, Markus H; Wrede, Christoph; Frosch, Maximilian; Prinz, Marco; Reich, Daniel S; Flügel, Alexander; Stadelmann, Christine; Fledrich, Robert; Nave, Klaus-Armin; Stassart, Ruth M.
Afiliación
  • Schäffner E; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Bosch-Queralt M; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Edgar JM; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Lehning M; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Strauß J; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Fleischer N; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Kungl T; Institute of Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
  • Wieghofer P; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Berghoff SA; Institute of Anatomy, Leipzig University, Leipzig, Germany.
  • Reinert T; Institute of Anatomy, Leipzig University, Leipzig, Germany.
  • Krueger M; Cellular Neuroanatomy, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
  • Morawski M; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Möbius W; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Barrantes-Freer A; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Stieler J; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Sun T; Institute of Anatomy, Leipzig University, Leipzig, Germany.
  • Saher G; Paul Flechsig Institute of Brain Research, Leipzig University, Leipzig, Germany.
  • Schwab MH; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Wrede C; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Frosch M; Paul Flechsig Institute of Brain Research, Leipzig University, Leipzig, Germany.
  • Prinz M; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Reich DS; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Flügel A; Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
  • Stadelmann C; Institute of Functional and Applied Anatomy, Research Core Unit Electron Microscopy, Hannover Medical School, Hannover, Germany.
  • Fledrich R; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
  • Nave KA; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
  • Stassart RM; Centre for NeuroModulation (NeuroModBasics), University of Freiburg, Freiburg, Germany.
Nat Neurosci ; 26(7): 1218-1228, 2023 07.
Article en En | MEDLINE | ID: mdl-37386131
Axonal degeneration determines the clinical outcome of multiple sclerosis and is thought to result from exposure of denuded axons to immune-mediated damage. Therefore, myelin is widely considered to be a protective structure for axons in multiple sclerosis. Myelinated axons also depend on oligodendrocytes, which provide metabolic and structural support to the axonal compartment. Given that axonal pathology in multiple sclerosis is already visible at early disease stages, before overt demyelination, we reasoned that autoimmune inflammation may disrupt oligodendroglial support mechanisms and hence primarily affect axons insulated by myelin. Here, we studied axonal pathology as a function of myelination in human multiple sclerosis and mouse models of autoimmune encephalomyelitis with genetically altered myelination. We demonstrate that myelin ensheathment itself becomes detrimental for axonal survival and increases the risk of axons degenerating in an autoimmune environment. This challenges the view of myelin as a solely protective structure and suggests that axonal dependence on oligodendroglial support can become fatal when myelin is under inflammatory attack.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalomielitis Autoinmune Experimental / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalomielitis Autoinmune Experimental / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos